EUVIMEDEUVIMED entdecken
Crossref

Radiofrequency and microwave ablation controls hepatic oligoprogression of advanced gastroenteropancreatic neuroendocrine tumors

Sami Matrood iD, Thomas Mathias Gress, Anja Rinke iD, Andreas Horst Mahnken

Journal of Neuroendocrinology · 2023

DOI: 10.1111/jne.13289 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neuroendocrinology, 2023. Verfasst von Sami Matrood und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Endocrinology, Metabolism and Infectiology, University Hospital Marburg, Marburg, Germany. Hauptthemen laut MEDLINE: Radiofrequency Ablation, Liver Neoplasms, Neuroendocrine Tumors, Catheter Ablation. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In progression of multifocal liver metastases of gastroenteropancreatic neuroendocrine tumors (GEP‐NET) escalation of systemic therapy is indicated. The aim of this retrospective study was to investigate the potential of local thermal ablation in hepatic oligoprogression and otherwise stable disease in GEP‐NET. Patients with hepatic oligoprogression and otherwise stable disease, who underwent radiofrequency ablation (RFA) or microwave ablation (MWA) for local control, were included in the study. Thermal ablation was performed while maintaining the ongoing systemic therapy or without addition of a systemic therapy. The effectiveness of this therapeutic approach was evaluated by determination of local treatment success, improvement of progression‐free survival (PFS) and the safety. Seventeen thermal ablation procedures were performed in 13 patients with well differentiated NET including seven ileum NET, four pancreatic NET, one appendix NET and one rectum NET. RFA and MWA of liver metastases were well tolerated without major complications. Thermal ablation resulted in an estimated median PFS of 62.6 weeks (mean 50.5 weeks; range 10.1–78.9 weeks) per procedure. In four patients, two ablation procedures were performed throughout the course of their disease resulting in an estimated median PFS of 69.1 weeks (mean 71.6 weeks; range 10.1–123.1 weeks) per patient. Start or change of systemic therapy could be delayed up to 123.1 weeks by using thermal ablations for isolated progression of single liver metastases. 88% of thermal ablations prolonged PFS. Thermal ablation of liver metastases in a non‐curative intent has the potential to provide focal growth control and to prolong PFS in GEP‐NET patients with hepatic oligoprogression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Radiofrequency AblationLiver NeoplasmsNeuroendocrine TumorsCatheter AblationIntestinal NeoplasmsRetrospective StudiesStomach NeoplasmsPancreatic NeoplasmsMicrowavesHumans

Stichwörter der Autor:innen

liver metastasismicrowave ablationneuroendocrine tumorradiofrequency ablation

Autor:innen und Institutionen

  • Department of Gastroenterology, Endocrinology, Metabolism and Infectiology, University Hospital Marburg, Marburg, Germany.
  • Department of Diagnostic and Interventional Radiology, University Hospital Marburg, Marburg, Germany.

ORCID-Profile: Sami Matrood, Anja Rinke

Zitieren

APA

Matrood, S., Gress, T. M., Rinke, A., & Mahnken, A. H. (2023). Radiofrequency and microwave ablation controls hepatic oligoprogression of advanced gastroenteropancreatic neuroendocrine tumors. Journal of Neuroendocrinology. https://doi.org/10.1111/jne.13289

Vancouver

Matrood S, Gress TM, Rinke A, Mahnken AH. Radiofrequency and microwave ablation controls hepatic oligoprogression of advanced gastroenteropancreatic neuroendocrine tumors. Journal of Neuroendocrinology. 2023. doi:10.1111/jne.13289

BibTeX
@article{Matrood2023,
  author = {Matrood, Sami and Gress, Thomas Mathias and Rinke, Anja and Mahnken, Andreas Horst},
  title = {Radiofrequency and microwave ablation controls hepatic oligoprogression of advanced gastroenteropancreatic neuroendocrine tumors},
  journal = {Journal of Neuroendocrinology},
  year = {2023},
  doi = {10.1111/jne.13289}
}
Kostenlos starten →